Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

Conditions: Type 1 Diabetes
Interventions: Drug: Anti-thymocyte globulin (ATG); Drug: verapamil extended release capsule; Drug: Placebo
Sponsors: University of Florida; University of Colorado, Denver; University of Miami
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments